$2.97 -0.02 (-0.67%)
2/10/2012 4:00 PM

Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 3 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Featured Broker Partners


Advertisement